High cure rates with grazoprevir-elbasvir with or without ribavirin guided by genotypic resistance testing among human immunodeficiency virus/hepatitis C virus-coinfected men who have sex with men | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

High cure rates with grazoprevir-elbasvir with or without ribavirin guided by genotypic resistance testing among human immunodeficiency virus/hepatitis C virus-coinfected men who have sex with men

Braun DL, Hampel B, Kouyos R, et al. High cure rates with grazoprevir-elbasvir with or without ribavirin guided by genotypic resistance testing among human immunodeficiency virus/hepatitis C virus-coinfected men who have sex with men. Clin Infect Dis. 2019;68(4):569-576.

Publication Type:

Journal Article

Authors:

Braun, DL; Hampel, B; Kouyos, R.; et, al

Source:

Clin Infect Dis, Volume 68, Issue 4, p.569-576 (2019)

Cited On:

Export Citation:

RIS Format

Top